title: Clozapine Treatment for Cabergoline-Induced Psychosis in a Patient With a Giant Prolactinoma.
authors.affiliation: From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Pérez-Esparza
authors.affiliation: From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).
authors.forename: Carlos Alberto
authors.initials: CA
authors.lastname: Rojas-Guerrero
authors.affiliation: From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).
authors.forename: Gerson Geovany
authors.initials: GG
authors.lastname: Andino-Rios
authors.affiliation: From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).
authors.forename: Patricia
authors.initials: P
authors.lastname: Arias-Garro
authors.affiliation: From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).
authors.forename: Jesús
authors.initials: J
authors.lastname: Ramírez-Bermúdez
authors.affiliation: From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).
authors.forename: Lesly
authors.initials: L
authors.lastname: Portocarrero-Ortiz
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000077465:Cabergoline / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D015175:Prolactinoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000209:etiology
chemical_list: D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D003024:Clozapine; D000077465:Cabergoline
keywords: cabergoline; clozapine; prolactinoma; psychosis